Former Insys execs ordered to pay $48.3 million in restitution in Subsys opioid trial

Insys Therapeutics' former top brass owes a collective $48.3 million in restitution for its role in the U.S. opioid crisis, a federal court in Boston ruled this month.

Insys founder John Kapoor will pay the bulk of that amount, while contributions from three former Insys executives will be capped at $5 million apiece, the United States District Court for the District of Massachusetts said in court documents filed last week.